Scholarlink

Background <p>The burden of <i>Helicobacter pylori</i> infection is exacerbated by rising antibiotic resistance. Probiotics, especially <i>Lactobacillus</i> species, have shown potential as adjunctive therapies for <i>H. pylori</i> infection. This study aimed to isolate a <i>Lactobacillus</i> strain from the gastric microbiome of healthy individuals and assess its probiotic properties against <i>H. pylori</i>.</p> Methods and results <p>Gastric biopsies were obtained from a cohort of 10 subjects, and used for bacterial isolation. The <i>Lactobacillus</i> strain was identified to species level using PCR and sequencing, followed by safety assessments. MTT assay was employed to measure AGS cell viability after exposure to various concentrations of <i>H. pylori</i>, as well as live and pasteurized <i>Lactobacillus</i>. Anti-inflammatory properties of the probiotic strain were assessed in AGS cells using RT-qPCR and ELISA. Additionally, the strain’s potential to inhibit <i>H. pylori</i> adhesion and invasion was examined. Probiotic <i>Lacticaseibacillus casei</i> strain RIGLD MG-1 was isolated and characterized as non-pathogenic and found to be tolerant to acidic and bile-rich environments, and susceptible to several antibiotics. Live and pasteurized <i>L. casei</i> downregulated the expression of <i>NF-κB</i>, <i>IL-8</i>, <i>TNF-α</i>, and <i>β-catenin</i>, meanwhile upregulated the expression of <i>IL-10</i> in <i>H. pylori</i>-treated cells. They also alleviated <i>H. pylori-</i>induced proinflammatory response by lowering IL-8 and TNF-α, and boosting IL-10 production. Additionally, both probiotic forms inhibited <i>H. pylori</i> adhesion and invasion in AGS cells.</p> Conclusion <p>Our results show that <i>L. casei</i> strain RIGLD MG-1 is safe and demonstrates significant immunomodulatory and anti-adhesion effects, making it a potential probiotic for use as adjunctive therapy to mitigate <i>H. pylori</i>-induced inflammation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Gastric microbiome-derived Lacticaseibacillus casei strain RIGLD MG-1 relieves Helicobacter pylori-induced inflammation in gastric epithelial cells in vitro

  • 期刊论文

  • 发表日期：

    2025年7月11日

查看全文
  • Masoomeh Ghasemipoor,
  • Mohammad Yaghoubi-Avini,
  • Masoumeh Azimirad,
  • Ali Nabavi-Rad,
  • Mehdi Azizmohammad Looha,
  • Michael Doulberis,
  • Christian Schulz,
  • Abbas Yadegar

摘要

Background

The burden of Helicobacter pylori infection is exacerbated by rising antibiotic resistance. Probiotics, especially Lactobacillus species, have shown potential as adjunctive therapies for H. pylori infection. This study aimed to isolate a Lactobacillus strain from the gastric microbiome of healthy individuals and assess its probiotic properties against H. pylori.

Methods and results

Gastric biopsies were obtained from a cohort of 10 subjects, and used for bacterial isolation. The Lactobacillus strain was identified to species level using PCR and sequencing, followed by safety assessments. MTT assay was employed to measure AGS cell viability after exposure to various concentrations of H. pylori, as well as live and pasteurized Lactobacillus. Anti-inflammatory properties of the probiotic strain were assessed in AGS cells using RT-qPCR and ELISA. Additionally, the strain’s potential to inhibit H. pylori adhesion and invasion was examined. Probiotic Lacticaseibacillus casei strain RIGLD MG-1 was isolated and characterized as non-pathogenic and found to be tolerant to acidic and bile-rich environments, and susceptible to several antibiotics. Live and pasteurized L. casei downregulated the expression of NF-κB, IL-8, TNF-α, and β-catenin, meanwhile upregulated the expression of IL-10 in H. pylori-treated cells. They also alleviated H. pylori-induced proinflammatory response by lowering IL-8 and TNF-α, and boosting IL-10 production. Additionally, both probiotic forms inhibited H. pylori adhesion and invasion in AGS cells.

Conclusion

Our results show that L. casei strain RIGLD MG-1 is safe and demonstrates significant immunomodulatory and anti-adhesion effects, making it a potential probiotic for use as adjunctive therapy to mitigate H. pylori-induced inflammation.